![](/img/cover-not-exists.png)
Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII)
Katja Klausz, Sven Berger, Jeroen J. Lammerts van Bueren, Stefanie Derer, Stefan Lohse, Michael Dechant, Jan G. J. van de Winkel, Matthias Peipp, Paul W. H. I. Parren, Thomas ValeriusVolume:
102
Year:
2011
Language:
english
Pages:
8
DOI:
10.1111/j.1349-7006.2011.02019.x
File:
PDF, 887 KB
english, 2011